Clinical Trial Update: Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating paclitaxel with or without lapatinib (GW572016) as first-line therapy for women with advanced or metastatic breast cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 3 | Status: COMPLETED | Results posted: 2014-03-31